Location: San Francisco, CA
CIK: 0001833486 · Show all filings
Period: Q4 2020 (Next →)
Filing Date: Feb 16, 2021
Total Value: $1.102B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | NGM Biopharmaceuticals Inc | 15,396,116 | $467M | 42.3% | $30.30 | — | COM | 62921N105 |
| NRIX | Nurix Therapeutics Inc | 5,383,333 | $177M | 16.1% | $33.14 | 0.0% | COM | 67080M103 |
| ORIC | ORIC Pharmaceuticals Inc. | 4,768,181 | $161M | 14.6% | $28.69 | 0.0% | COM | 68622P109 |
| RVMD | Revolution Medicines Inc | 3,580,252 | $142M | 12.9% | $39.54 | 0.0% | COM | 76155X100 |
| — | RAPT Therapeutics Inc | 3,885,679 | $76.74M | 7.0% | $19.75 | — | COM | 75382E109 |
| — | Constellation Pharmaceuticals Inc. | 2,626,631 | $75.65M | 6.9% | $28.80 | — | COM | 210373106 |
| — | Gritstone Oncology Inc | 869,493 | $3.426M | 0.3% | $3.94 | — | COM | 39868T105 |